The therapeutic effect of combined use of tolterodine and tamsulosin for benign prostate hyperplasia.
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Tamsulosin (Primary) ; Tolterodine (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 04 Apr 2017 Primary endpoint (Urinary flow rate (Endpoints are maximum urinary flow rate and average urinary flow rate.)) has been met.
- 04 Apr 2017 Primary endpoint (Quality of life) has been met.
- 04 Apr 2017 Primary (International Prostate Symptom Score) endpoint has been met.